Hypoxia-Mediated Down-Regulation of Bid and Bax in Tumors Occurs via Hypoxia-Inducible Factor 1-Dependent and -Independent Mechanisms and Contributes to Drug Resistance

REFERENCES

• Adams, J. M., and Cory S.. 1998. The Bcl-2 protein family: arbiters of cell survival. Science 281:1322–1326.
   PubMed Web of Science ®Google Scholar
• Akakura, N., Kobayashi M., Horiuchi I., Suzuki A., Wang J., Chen J., Niizeki H., Kawamura K., Hosokawa M., and Asaka M.. 2001. Constitutive expression of hypoxia-inducible factor-1α renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res. 61:6548–6554.
   PubMed Web of Science ®Google Scholar
• Baek, J. H., Jang J. E., Kang C. M., Chung H. Y., Kim N. D., and Kim K. W.. 2000. Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis. Oncogene 19:4621–4631.
   PubMed Web of Science ®Google Scholar
• Birner, P., Schindl M., Obermair A., Breitenecker G., and Oberhuber G.. 2001. Expression of hypoxia-inducible factor 1α in epithelial ovarian tumors: its impact on prognosis and response to chemotherapy. Clin. Cancer Res. 7:1661–1668.
   PubMed Web of Science ®Google Scholar
• Bos, R., Zhong H., Hanrahan C. F., Mommers E. C., Semenza G. L., Pinedo H. M., Abeloff M. D., Simons J. W., van Diest P. J., and van der Wall E.. 2001. Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J. Natl. Cancer Inst. 93:309–314.
   PubMed Web of Science ®Google Scholar
• Brown, J. M., and Wouters B.. 2001. Apoptosis: mediator or mode of cell killing by anticancer drugs? Drug Resist. Updates 4:135–136.
   PubMedGoogle Scholar
• Bruick, R. K. 2000. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc. Natl. Acad. Sci. USA 97:9082–9087.
   PubMed Web of Science ®Google Scholar
• Carmeliet, P., Dor Y., Herbert J. M., Fukumura D., Brusselmans K., Dewerchin M., Neeman M., Bono F., Abramovitch R., Maxwell P., Koch C. J., Ratcliffe P., Moons L., Jain R. K., Collen D., Keshert E., and Keshet E.. 1998. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394:485–490.
   PubMed Web of Science ®Google Scholar
• Cheng, E. H., Wei M. C., Weiler S., Flavell R. A., Mak T. W., Lindsten T., and Korsmeyer S. J.. 2001. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell 8:705–711.
   PubMed Web of Science ®Google Scholar
• Degli Esposti, M., Erler J. T., Hickman J. A., and Dive C.. 2001. Bid, a widely expressed proapoptotic protein of the Bcl-2 family, displays lipid transfer activity. Mol. Cell. Biol. 21:7268–7276.
   PubMedGoogle Scholar
• DePreter, K., Speleman F., Combaret V., Lunec J., Lautreys G., Eussen B. H., Francotte N., Board J., Pearson A. D., De Paepe A., Van Roy N., and Vandesompele J.. 2002. Quantification of MYCN, DDX1 and NAG gene copy number in neuroblastoma using real time quantitative PCR assay. Mod. Pathol. 15:59–66.
   PubMedGoogle Scholar
• Dive, C., and Hickman J. A.. 1991. Drug target interactions: only the first step in the commitment of a cell to a programmed cell death. Br. J. Cancer 64:192–196.
   PubMed Web of Science ®Google Scholar
• Dong, Z., Venkatachalam M. A., Wang J., Patel Y., Saikumar P., Semenza G. L., Force T., and Nishiyana J.. 2001. Up-regulation of apoptosis inhibitory protein IAP-2 by hypoxia. HIF-1-independent mechanisms. J. Biol. Chem. 276:18702–18709.
   PubMedGoogle Scholar
• Eskes, R., Desagher S., Antonsson B., and Martinou J.-C.. 2000. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol. Cell. Biol. 20:929–935.
   PubMed Web of Science ®Google Scholar
• Graeber, T. G., Osmanian C., Jacks T., Housman D. E., Koch S. J., Lowe S. W., and Giaccia A. J.. 1996. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379:88–91.
   PubMed Web of Science ®Google Scholar
• Griffiths, J. R., McSheehy P. M., Robinson S. P., Troy H., Chung Y. L., Leek R. D., Williams K. J., J Stratford I., Harris A. L., and Stubbs M.. 2002. Metabolic changes detected by in vivo magnetic resonance studies of HEPA-1 wild-type tumors and tumors deficient in hypoxia-inducible factor-1beta (HIF-1beta): evidence of an anabolic role for the HIF-1 pathway. Cancer 62:688–695.
   Google Scholar
• Guo, K., Searfossm G., Krolikowskim D., Pagnoni M., Granksm C., Clark K., Yu K. T., Jaye M., and Ivashchenko Y.. 2001. Hypoxia induces the expression of the pro-apoptotic gene BNIP3. Cell Death Differ. 8:367–376.
   PubMed Web of Science ®Google Scholar
• Hopfl, G., Wenger R. H., Ziegler U., Stallmach T., Gardelle O., Achermann R., Wergin M., Kaser-Hotz B., Saunders H. M., Williams K., Stratford I., Gassman M., and Desbaillets I.. 2002. Rescue of hypoxia-inducible factor-1alpha-deficient tumor growth by wild-type cells is independent of vascular endothelial growth factor. Cancer Res. 62:2962–2970.
   PubMedGoogle Scholar
• Jiang, B. H., Agani F., Passaniti A., and Semenza G. L.. 1997. V-Src induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumour progression. Cancer Res. 57:5328–5335.
   PubMed Web of Science ®Google Scholar
• Johnstone, R. W., Ruefi A. A., and Lowe S. W.. 2002. Apoptosis: a link between cancer genetics and chemotherapy. Cell 108:153–164.
   PubMed Web of Science ®Google Scholar
• Kalra, R., Jones A.-M., Kirk J., Adams G. E., and Stratford I. J.. 1993. The effect of hypoxia on acquired drug resistance and response to epidermal growth factor in Chinese hamster lung fibroblasts and human breast cancer cells in vitro. Int. J. Cancer 54:650–655.
   PubMedGoogle Scholar
• Kinoshita, M., Johnson D. L., Shatney C. H., Lee Y. L., and Mochizuki H.. 2001. Cancer cells surviving hypoxia obtain hypoxia resistance and maintain anti-apoptotic potential under reoxygenation. Int. J. Cancer 91:322–326.
   PubMedGoogle Scholar
• Koumenis, C., Naczki C., Koritzinsky M., Rastani S., Diehl A., Sonenberg N., Koromilas A., and Wouters B. G.. 2002. Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2α. Mol. Cell. Biol. 22:7405–7416.
   PubMed Web of Science ®Google Scholar
• LeBlanc, H., Lawrence D., Varfolomeev E., Totpal K., Morlan J., Schow P., Fong S., Schwall R., Sinicropi D., and Ashkenazi A.. 2002. Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. Nat. Med. 8:274–281.
   PubMed Web of Science ®Google Scholar
• Letai, A., Bassik M. C., Walensky L. D., Sorcinelli M. D., Weiler S., and Korsmeyer J.. 2002. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2:183–192.
   PubMed Web of Science ®Google Scholar
• Makin, G., and Dive C.. 2001. Apoptosis and cancer chemotherapy. Trends Cell Biol. 11:S22–S26.
   PubMed Web of Science ®Google Scholar
• Maxwell, P. H., Dachs G. U., Gleadle J. M., Nicholls L. G., Harris A. L., Stratford I. J., Hankinson O., Pugh C. W., and Ratcliffe P.. 1997. Hypoxia-inducible factor-1 modulates gene expression in solid tumours and influences both angiogenesis and tumour growth. Proc. Natl. Acad. Sci. USA 94:8104–8109.
   PubMed Web of Science ®Google Scholar
• McClintock, D. S., Santore M. T., Lee V. Y., Brunelle J., Scott Bidinger G. R., Zong W.-X., Thompson C. B., Hay N., and Chandel N. S.. 2002. Bcl-2 family members and functional electron transport chain regulate oxygen deprivation-induced cell death. Mol. Cell. Biol. 22:94–104.
   PubMed Web of Science ®Google Scholar
• Narravula, S., and Colgan S. P.. 2001. Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor α expression during hypoxia. J. Immunol. 166:7543–7548.
   PubMed Web of Science ®Google Scholar
• Park, S. Y., Billiar T. R., and Seol D. W.. 2002. Hypoxia inhibition of apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Biochem. Biophys. Res. Commun. 291:150–153.
   PubMed Web of Science ®Google Scholar
• Raleigh, J. A., Chou S. C., Arteel G. E., and Horsman M. R.. 1999. Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat. Res. 151:580–589.
   PubMed Web of Science ®Google Scholar
• Rampino, N., Yamamoto H., Ionov Y., Li Y., Sawai H., Reed J. C., and Perucho M.. 1997. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275:967–969.
   PubMed Web of Science ®Google Scholar
• Ryan, H. E., Lo J., and Johnson R. S.. 1998. HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J. 17:3005–3015.
   PubMed Web of Science ®Google Scholar
• Ryan, H. E., Poloni M., McNutty W., Elson D., Grassmann M., Arbeit J. M., and Johnson R. S.. 2000. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res. 60:4010–4015.
   PubMed Web of Science ®Google Scholar
• Sax, J. K., Fei P., Murphy M. E., Bernhard E., Korsmeyer S. J., and El-Deiry W. S.. 2002. BID regulation by p53 contributes to chemosensitivity. Nat. Cell Biol. 4:842–849.
   PubMed Web of Science ®Google Scholar
• Scaffidi, C., Schmitz I., Zha J., Korsmeyer S. J., Krammer P. H., and Peter M. E.. 1999. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J. Biol. Chem. 6:22532–22538.
   Google Scholar
• Schmitt, C. A., and Lowe S. W.. 2001. Apoptosis is critical for drug response in vivo. Drug Resist. Updates 4:132–134.
   PubMed Web of Science ®Google Scholar
• Semenza, G. L., Jiang B. H., Leung S. W., Passantino R., Concordet J. P., Maire P., and Giallongo A.. 1996. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem. 271:32529–32537.
   PubMed Web of Science ®Google Scholar
• Semenza, G. L. 2002. HIF-1 and tumour progression: pathophysiology and therapeutics. Trends Mol. Med. 8:S62–S67.
   PubMed Web of Science ®Google Scholar
• Smith, E., Stratford I. J., and Adams G. E.. 1980. Cytotoxicity of adriamycin on aerobic and hypoxic Chinese hamster V79 cells in vitro. Br. J. Cancer 41:568–573.
   Web of Science ®Google Scholar
• Sowter, H. S., Ratcliffe P. J., Watson P., Greenberg A. H., and Harris A. L.. 2001. HIF-1-dependent regulation of hypoxic induction of cell death factors BNIP3 and NIX in human tumors. Cancer Res. 61:6669–6673.
   PubMed Web of Science ®Google Scholar
• Stratford, I. J., Patterson A. V., Dachs G. U., Telfer B., and Williams K.. 1999. Hypoxia-mediated gene expression, p. 107–113. In Vaupel P. and Kelleher D. K. (ed.), Tumour hypoxia: pathophysiology, clinical significance and therapeutic perspectives. Wissenchaftliche Verlagsgeselschaft GmbH, Stuttgart, Germany.
   Google Scholar
• Sui, G., Soohoo C., Affar E. B., Gay F., Shi Y., Forrester W. C., and Shi Y.. 2002. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. USA 99:5515–5520.
   PubMed Web of Science ®Google Scholar
• Swanson, H. I. 2002. DNA binding and protein interactions of the AHR/ARNT heterodimer that facilitate gene activation. Chem.-Biol. Interact. 141:63–76.
   PubMed Web of Science ®Google Scholar
• Teicher, B. A. 1994. Hypoxia and drug resistance. Cancer Metastasis Rev. 13:139–168.
   PubMed Web of Science ®Google Scholar
• Theodorakis, P., Lomonosova E., and Chinnadurai D.. 2002. Critical requirement of BAX for manifestation of apoptosis induced by multiple stimuli in human epithelial cancer cells. Cancer Res. 62:3373–3376.
   PubMed Web of Science ®Google Scholar
• Thomas, D. A., Scorrano L., Putcha G. V., Korsmeyer S. J., and Ley T. J.. 2001. Granzyme B can cause mitochondrial depolarisation and cell death in the absence of BID, BAX and BAK. Proc. Natl. Acad. Sci. USA 98:14985–14990.
   PubMedGoogle Scholar
• Violette, S., Poulain L., Dussaulx E., Pepin D., Faussat A. M., Chambaz J., Lacorte J. M., Staedel C., and Lesuffleur T.. 2002. Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2, Bcl-xl in addition to BAX and p53 status. Int. J. Cancer 98:498–504.
   PubMed Web of Science ®Google Scholar
• Wang, G. 1995. Hypoxia-inducible factor 1 is a basic helix-loop-helix-PAS heterodimer regulated by cellular oxygen tension. Proc. Natl. Acad. Sci. USA 92:5510–5514.
   PubMed Web of Science ®Google Scholar
• Wei, M. C., Lindsten T., Mootha V. K., Weiler S., Gross A., Ashiya M., Thompson C. B., and Korsmeyer S. J.. 2000. tBid, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev. 14:2060–2071.
   PubMed Web of Science ®Google Scholar
• Wei, M. C., Zong W. X., Cheng E. H., Lindsten T., Panoutsakopoulou V., Ross A. J., Roth K. A., MacGregor G. R., Thompson C. B., and Korsmeyer S. J.. 2001. Pro-apoptotic Bax and Bak: a requisite gateway to mitochondrial dysfunction and death. Science 292:727–730.
   PubMed Web of Science ®Google Scholar
• Wenger, R. H., and Gassman M.. 1997. Oxygen(es) and the hypoxia-inducible factor-1. Biol. Chem. 378:609–616.
   PubMed Web of Science ®Google Scholar
• West, C., Stratford I. J., Barrass N., and Smith E.. 1981. A comparison of adriamycin and mAMSA in vitro: cell lethality and sister chromatid exchange studies. Br. J. Cancer 44:798–809.
   PubMedGoogle Scholar
• Williams, K. J., Telfer B. A., Airley R. E., Peters H. P., Sheridan M. R., van der Kogel A. J., Harris A. L., and Stratford I. J.. 2002. A protective role for HIF-1 in response to redox manipulation and glucose deprivation: implications for tumorigenesis. Oncogene 21:282–290.
   PubMed Web of Science ®Google Scholar
• Wood, S. M., Wiesener M. S., Yeates K. M., Okada N., Pugh C. W., Maxwell P. H., and Ratcliffe P. J.. 1998. Selection and analysis of a mutant cell line defective in the hypoxia-inducible factor-1α-subunit (HIF-1α). J. Biol. Chem. 273:8360–8368.
   PubMed Web of Science ®Google Scholar
• Wykoff, C. C., Beasley N. J., Watson P. H., Turner K. J., Pastorek J., Sibtain A., Wilson G. D., Turley H., Talks K. L., Maxwell P. H., Pugh C. W., Ratcliffe P. J., and Harris A. L.. 2000. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 60:7075–7083.
   PubMed Web of Science ®Google Scholar
• Wykoff, C. C., Pugh C. W., Harris A. L., Maxwell P. H., and Ratcliffe P. J.. 2001. The HIF pathway: implications for patterns of gene expression in cancer. Novartis Found. Symp. 240:212–225.
   PubMedGoogle Scholar
• Yang, E., Zha J., Jockel J., Boise L. H., Thompson C. B., and Korsmeyer S. J.. 1995. Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death. Cell 80:285–291.
   PubMed Web of Science ®Google Scholar
• Zhang, L., Yu J., Park B. H., Kinzler K. W., and Vogelstein B.. 2000. Role of BAX in the apoptotic response to anticancer agents. Science 290:989–992.
   PubMed Web of Science ®Google Scholar
• Zhong, H., Agani F., Baccala A. A., Laughner E., Rioseco-Camacho N., Isaacs W. B., Simons J. W., and Semenza G. L.. 1998. Increased expression of hypoxia-inducible factor-1α in rat and human prostate cancer. Cancer Res. 58:5280–5284.
   PubMed Web of Science ®Google Scholar
• Zhong, H., De Marzom A. M., Laughnerm E., Lim M., Hilton D. A., Zagzag D., Buechler P., Isaacs W. B., Semenza G. L., and Simons J. W.. 1999. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 59:5830–5835.
   PubMed Web of Science ®Google Scholar
• Zhong, H., and Simons J. W.. 1999. Direct comparison of GAPDH, beta-actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia. Biochem. Biophys. Res. Commun. 259:523–526.
   PubMed Web of Science ®Google Scholar